Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of the Xpert Clostridium difficile Assay for the Diagnosis of Clostridium difficile Infection

  • Shin, Saeam (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine) ;
  • Kim, Minkyung (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine) ;
  • Kim, Myungsook (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine) ;
  • Lim, Heejung (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine) ;
  • Kim, Heejung (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine) ;
  • Lee, Kyungwon (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine) ;
  • Chong, Yunsop (Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine)
  • Published : 2012.09.01
⟨ Previous Next ⟩

Abstract

Infection with Clostridium difficile is a growing concern because of the increasing prevalence and spread of nosocomial infections. Emergence of the hypervirulent 027/NAP1/BI strain is also notable. Existing diagnostic methods have low sensitivity or are time-consuming. Therefore, establishing a rapid and accurate microbiological diagnostic assay is needed. We evaluated the Xpert C. difficile assay (Xpert CD assay; Cepheid, USA) to detect toxigenic C. difficile. This assay is a real-time multiplex PCR assay that can be used to detect toxigenic C. difficile strains and differentiate the C. difficile presumptive 027/NAP1/BI strain. A total of 253 loose stool specimens were collected and toxigenic cultures, VIDAS C. difficile A & B assays (VIDAS CDAB assay; bioM$\acute{e}$rieux, France), and the Xpert CD assay were performed. In comparison to toxigenic cultures, the sensitivity, specificity, and positive and negative predictive values were 100%, 94.6%, 83.1%, and 100%, respectively, for the Xpert CD assay and 40.8%, 98.0%, 100%, and 88.9%, respectively, for VIDAS CDAB assay. Because of the low prevalence of the PCR ribotype 027 in Korea, the evaluation of the usefulness of the Xpert CD assay for screening for the 027 strain was limited. The Xpert CD assay provides great sensitivity in diagnosing toxigenic C. difficile infection. In addition, this method has excellent usability because it is simple and fast.

Keywords

References

  1. Kelly CP and LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med 2008;359:1932-40. https://doi.org/10.1056/NEJMra0707500
  2. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005;353:2433-41. https://doi.org/10.1056/NEJMoa051590
  3. Barbut F, Mastrantonio P, Delmée M, Brazier J, Kuijper E, Poxton I. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 2007;13:1048-57. https://doi.org/10.1111/j.1469-0691.2007.01824.x
  4. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-84. https://doi.org/10.1016/S0140-6736(05)67420-X
  5. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hospital Epidemiol 2010;31:431-55. https://doi.org/10.1086/651706
  6. Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, et al. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008;8:777-84. https://doi.org/10.1016/S1473-3099(08)70233-0
  7. Terhes G, Urban E, Soki J, Hamid KA, Nagy E. Community-acquired Clostridium difficile diarrhea caused by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary. J Clin Microbiol 2004;42:4316-8. https://doi.org/10.1128/JCM.42.9.4316-4318.2004
  8. O'Neill GL, Ogunsola FT, Brazier JS, Duerden BI. Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 1996;2:205-9. https://doi.org/10.1006/anae.1996.0028
  9. Spigaglia P and Mastrantonio P. Comparative analysis of Clostridium difficile clinical isolates belonging to different genetic lineages and time periods. J Med Microbiol 2004;53:1129-36. https://doi.org/10.1099/jmm.0.45682-0
  10. Babady NE, Stiles J, Ruggiero P, Khosa P, Huang D, Shuptar S, et al. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J Clin Microbiol 2010;48:4519-24. https://doi.org/10.1128/JCM.01648-10
  11. Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008;47:1162-70. https://doi.org/10.1086/592257
  12. Kim H, Lee Y, Moon HW, Lim CS, Lee K, Chong Y. Emergence of Clostridium difficile ribotype 027 in Korea. Korean J Lab Med 2011;31:191-6. https://doi.org/10.3343/kjlm.2011.31.3.191
  13. Kim H, Jeong SH, Roh KH, Hong SG, Kim JW, Shin MG, et al. Investigation of toxin gene diversity, molecular epidemiology, and antimicrobial resistance of Clostridium difficile isolated from 12 hospitals in South Korea. Korean J Lab Med 2010;30:491-7. https://doi.org/10.3343/kjlm.2010.30.5.491
  14. Huang H, Weintraub A, Fang H, Nord CE. Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of Clostridium difficile infections. J Clin Microbiol 2009;47:3729-31. https://doi.org/10.1128/JCM.01280-09
  15. Tenover FC, Akerlund T, Gerding DN, Goering RV, Bostrom T, Jonsson AM, et al. Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol 2011;49:1831-7. https://doi.org/10.1128/JCM.02446-10

Cited by

  1. Indeterminate tcdB using a Clostridium difficile PCR assay: a retrospective cohort study vol.13, pp.None, 2012, https://doi.org/10.1186/1471-2334-13-324
  2. Molecular methods in the diagnosis of Clostridium difficile infections: an update vol.13, pp.7, 2012, https://doi.org/10.1586/14737159.2013.829705
  3. Epidemiology and clinical features of toxigenic culture-confirmed hospital-onset Clostridium difficile infection: a multicentre prospective study in tertiary hospitals of South Korea vol.63, pp.11, 2012, https://doi.org/10.1099/jmm.0.070672-0
  4. Isolation of Clostridium Difficile and Detection of A and B Toxins Encoding Genes vol.2, pp.1, 2012, https://doi.org/10.17795/ijep15238
  5. Evaluation of the Selective Enrichment Culture to Recover Clostridium difficile vol.46, pp.4, 2012, https://doi.org/10.15324/kjcls.2014.46.4.140
  6. Molecular Epidemiology ofClostridium difficileInfections in Children: A Retrospective Cohort Study vol.36, pp.4, 2015, https://doi.org/10.1017/ice.2014.89
  7. The yield of stool testing in hospital-onset diarrhea: Has evidence changed practice? vol.43, pp.3, 2015, https://doi.org/10.1080/21548331.2015.1064757
  8. Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions vol.35, pp.2, 2016, https://doi.org/10.1097/inf.0000000000000954
  9. Selected Topics in Anaerobic Bacteriology vol.4, pp.4, 2016, https://doi.org/10.1128/microbiolspec.dmih2-0015-2015
  10. Disparate prevalence of toxigenic and nontoxigenic Clostridium difficile among distinct adult patient populations in a single institution vol.65, pp.11, 2016, https://doi.org/10.1099/jmm.0.000350
  11. Current knowledge on the laboratory diagnosis of Clostridium difficile infection vol.23, pp.9, 2017, https://doi.org/10.3748/wjg.v23.i9.1552
  12. Accuracy of Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection: A meta analysis vol.12, pp.10, 2017, https://doi.org/10.1371/journal.pone.0185891
  13. Point-of-Care Diagnostics for Infectious Diseases: Present and Future vol.93, pp.2, 2012, https://doi.org/10.3904/kjm.2018.93.2.181
  14. Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital vol.73, pp.5, 2012, https://doi.org/10.1093/jac/dkx523
  15. Performance comparison of the cobas Liat and Cepheid GeneXpert systems for Clostridium difficile detection vol.13, pp.7, 2018, https://doi.org/10.1371/journal.pone.0200498
  16. Failure of metagenomics in detecting emerging pathogens, the Clostridium difficile paradigm vol.78, pp.5, 2012, https://doi.org/10.1016/j.jinf.2019.02.014
  17. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) di vol.32, pp.3, 2019, https://doi.org/10.1128/cmr.00032-18
  18. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children vol.21, pp.5, 2012, https://doi.org/10.1111/tid.13149
  19. Healthcare associated Clostridioides difficile infection in adult surgical and medical patients hospitalized in tertiary hospital in Belgrade, Serbia: a seven years prospective cohort study vol.15, pp.1, 2012, https://doi.org/10.1080/19932820.2019.1708639
  20. Natural Clostridioides difficile Toxin Immunization in Colonized Infants vol.70, pp.10, 2012, https://doi.org/10.1093/cid/ciz582
  21. Laboratory Diagnostic Methods for Clostridioides difficile Infection: the First Systematic Review and Meta-analysis in Korea vol.41, pp.2, 2012, https://doi.org/10.3343/alm.2021.41.2.171
  22. Evaluation of the Cepheid Xpert C. difficile diagnostic assay: an update meta-analysis vol.52, pp.4, 2012, https://doi.org/10.1007/s42770-021-00563-7